Evgeny Izumchenko
Consultant / Advisor chez AYALA PHARMACEUTICALS, INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Aleksandrs Zhavoronkov | M | - |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
LongeVC
 LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 10 ans |
| Garri Zmudze | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 8 ans |
| Ren Feng | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
| Ken Berlin | M | 59 | 6 ans | |
| David Sidransky | M | 64 | 7 ans | |
| Aleksandr Aliper | M | 34 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 10 ans |
| Steven Kenneth Galson | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
| Roni Appel | M | 57 | 20 ans | |
| Sergey Jakimov | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 4 ans |
| Vered Bisker-Leib | M | 53 | 4 ans | |
| Evelyne Bischof | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 5 ans |
| Ilya Suharenko | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 4 ans |
| Robert Spiegel | M | 73 | 7 ans | |
| Murray Goldberg | M | 79 | 7 ans | |
| Konstantinos Maitos | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 4 ans |
| Michael Levitt | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | - |
| Tzipi Strauss | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | - |
| Fishman Gregory | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 3 ans |
| Christine Huang | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | - |
| Kan Chen | - | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
| Luis Angel | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | - |
| Min Fang | M | 45 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
| Sergejs Jakimovs | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 8 ans |
| Miro Venturi | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | - |
| Carmit Nadri-Shay | M | - | 6 ans | |
| Kan Chen | M | 42 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
| Irit Klipper-Avni | F | - | 5 ans | |
| Amrita Jain | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | 3 ans |
| Yuval Cabilly | M | 44 | 1 ans | |
| Bridget Martell | M | 58 | 1 ans | |
| Roy Golan | M | 50 | 1 ans | |
| Shmuel Tuvia | M | - | 2 ans | |
| Pini Orbach | M | - | 1 ans | |
| Dana Gelbaum | F | - | - | |
| Mike Martin | M | - |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Evgeny Ivanovich Gritsenko | M | - |
Ben-Gurion University of the Negev
Repair Biotechnologies, Inc.
 Repair Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Repair Biotechnologies, Inc. operates as a biotechnology company which develops clinic therapies. It specializes in developing reversing atherosclerosis and atrophy of the thymus. The company was founded by Reason Cherman and Bill Cherman in 2018 and is headquartered in Syracuse, NY. | 12 ans |
| Lina Kaminski | M | - |
Ben-Gurion University of the Negev
| 10 ans |
| Keren Kocshitzki | F | - |
Ben-Gurion University of the Negev
| 2 ans |
| Keren Dykman | F | 53 |
Ben-Gurion University of the Negev
| 9 ans |
| Alon Heller | M | 47 |
Ben-Gurion University of the Negev
| 8 ans |
| Yohanan Nahon | M | 54 |
Ben-Gurion University of the Negev
| 8 ans |
| Idan Zu-Artez | M | 51 |
Ben-Gurion University of the Negev
| 7 ans |
| Asaf Toker | M | 51 |
Ben-Gurion University of the Negev
| 5 ans |
| Uri Shochat | M | 56 |
Ben-Gurion University of the Negev
| 8 ans |
| Peter Raihelgauz | M | - |
Ben-Gurion University of the Negev
| 5 ans |
| Lior Goldenberg | M | - |
Ben-Gurion University of the Negev
| 5 ans |
| Assaf Mansour | M | 52 |
Ben-Gurion University of the Negev
| 7 ans |
| Assaf Araki | M | - |
Ben-Gurion University of the Negev
| 7 ans |
| Ido Shavit | M | 52 |
Ben-Gurion University of the Negev
| 9 ans |
| Tamir Amar | M | 50 |
Ben-Gurion University of the Negev
| 6 ans |
| Terry Yaskil | M | 50 |
Ben-Gurion University of the Negev
| 5 ans |
| Guy Beit-Or | M | - |
Ben-Gurion University of the Negev
| 6 ans |
| Tal Tsfany | M | - |
Ben-Gurion University of the Negev
| 6 ans |
| Gal Shofrony | M | 40 |
Ben-Gurion University of the Negev
| 4 ans |
| Guy Ben Ezra | M | 52 |
Ben-Gurion University of the Negev
| 4 ans |
| Tamar Harel Adar | M | 46 |
Ben-Gurion University of the Negev
| 1 ans |
| Erez Didi | M | 38 |
Ben-Gurion University of the Negev
| 4 ans |
| Kobi Bentkovski | M | 51 |
Ben-Gurion University of the Negev
| 2 ans |
| Roni Haimof | M | 60 |
Ben-Gurion University of the Negev
| 1 ans |
| Avi Shukrun Cohen | M | 53 |
Ben-Gurion University of the Negev
| 4 ans |
| Ofir Laor | M | - |
Ben-Gurion University of the Negev
| 3 ans |
| Yoni Blau | M | - |
Ben-Gurion University of the Negev
| 1 ans |
| Erez Steinberg | M | 47 |
Ben-Gurion University of the Negev
| 4 ans |
| Dana Shild | F | 46 |
Ben-Gurion University of the Negev
| 4 ans |
| Racheli Kogan | F | - |
Ben-Gurion University of the Negev
| 3 ans |
| Rotem Hochma | F | 44 |
Ben-Gurion University of the Negev
| 4 ans |
| Hadar Siterman Norris | F | - |
Ben-Gurion University of the Negev
| 3 ans |
| Adi Toledano | M | - |
Ben-Gurion University of the Negev
| 4 ans |
| Yonatan Naveh | M | - |
Ben-Gurion University of the Negev
| 4 ans |
| David Ashkenazi | M | - |
Ben-Gurion University of the Negev
| 3 ans |
| Iden Erdan | M | - |
Ben-Gurion University of the Negev
| 3 ans |
| Lihi Lubranski | F | - |
Ben-Gurion University of the Negev
| 4 ans |
| Erez Yefet | M | 38 |
Ben-Gurion University of the Negev
| 4 ans |
| Yaacov Nagar | M | - |
Ben-Gurion University of the Negev
| 4 ans |
| Tal Bereznitskey | M | - |
Ben-Gurion University of the Negev
| 3 ans |
| Yitzhak Peterburg | M | 73 |
Ben-Gurion University of the Negev
| 12 ans |
| Gadi Lesin | M | 57 |
Ben-Gurion University of the Negev
| 2 ans |
| Galia Malka | F | 52 |
Ben-Gurion University of the Negev
| 2 ans |
| Arnon Kraemer | M | - |
Ben-Gurion University of the Negev
| 2 ans |
| Ainat Koller | F | - |
Ben-Gurion University of the Negev
| 2 ans |
| Ronen Perez | M | - |
Ben-Gurion University of the Negev
| 4 ans |
| Jacob Daddon | M | - |
Ben-Gurion University of the Negev
| 4 ans |
| Noa Weitz Fleischer | F | 38 |
Ben-Gurion University of the Negev
| 4 ans |
| Moshy Cohen-Nehemia | M | 54 |
Ben-Gurion University of the Negev
| 2 ans |
| Tal Zaks | M | 58 |
Ben-Gurion University of the Negev
| 14 ans |
| Yossef Halfon | M | 57 |
Ben-Gurion University of the Negev
| 2 ans |
| Uri Alon | M | 53 |
Ben-Gurion University of the Negev
| 2 ans |
| Amir Brami | M | 40 |
Ben-Gurion University of the Negev
| 4 ans |
| Shiran Lahav-Nidam | F | 48 |
Ben-Gurion University of the Negev
| 2 ans |
| Avior Teboul | M | 40 |
Ben-Gurion University of the Negev
| 4 ans |
| Yonit Tsvi Tabibi | F | 47 |
Ben-Gurion University of the Negev
| 4 ans |
| Chanan Adler | M | 48 |
Ben-Gurion University of the Negev
| 4 ans |
| Yoav Knoll | M | - |
Ben-Gurion University of the Negev
| 3 ans |
| Sivan Yedidsion | F | 43 |
Ben-Gurion University of the Negev
| 4 ans |
| Nir Sosinsky | M | 47 |
Ben-Gurion University of the Negev
| 4 ans |
| Atad Peled | M | - |
Ben-Gurion University of the Negev
| 3 ans |
| Eitan Shabtay | M | 54 |
Ben-Gurion University of the Negev
| 2 ans |
| Amit Moshe | M | 40 |
Ben-Gurion University of the Negev
| 4 ans |
| Sagit Sabag | F | 39 |
Ben-Gurion University of the Negev
| 4 ans |
| Lior Fleishman | M | - |
Ben-Gurion University of the Negev
| 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Israël | 65 | 65,00% |
| Etats-Unis | 24 | 24,00% |
| Suisse | 15 | 15,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Evgeny Izumchenko
- Réseau Personnel
